EMILY SHAFFER: Open Payments
NPI 1346924081 · FAIRFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 18 payments from 11 companies in 2025. Trend: 2023 $14 · 2024 $249 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $124 |
| Novartis Pharmaceuticals Corporation | 4 | $71 |
| Aveo Pharmaceuticals, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Eisai Inc. | 2 | $38 |
| Janssen Biotech, Inc. | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Smith+Nephew, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Incyte Corporation | 1 | $18 |
Products named: JEMPERLI, KISQALI, FOTIVDA, FRUZAQLA, Lenvima, KEYTRUDA, COLLAGENASE SANTYL, VERZENIO.
Industry payments across OH — which companies pay providers there.
